Chris Wolfe
Officer at DA32 Life Science Tech Acquisition Corp. (DALS)
Chris Wolfe has filed 6 insider reports with the SEC since August 2021, as director at SelectQuote, Inc. (SLQT) and officer at DA32 Life Science Tech Acquisition Corp. (DALS). The latest filing, on November 14, 2026, reports grant or award and exercise or conversion of a derivative at SelectQuote, Inc. (SLQT).
- Filings
- 6
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Chris Wolfe is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince February 2025 | 115,752 | $5.01 | Nov 14, 2026 | ||||
| Officer | Aug 10, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 10, 2026SLQTDirector Wolfe Chris converted options into 106,250 shares, increasing direct ownership by 1,118% to 115,752 unitsForm 4Grant or awardExercise or conversion of a derivative
- Feb 28, 2026SLQTDirector Wolfe Chris converted options into 9,502 sharesForm 4Exercise or conversion of a derivative
- Nov 11, 2025SLQTSEC Form 4 filed by Director Wolfe ChrisForm 4Grant or award
- Feb 28, 2025SLQTSEC Form 4 filed by Director Wolfe ChrisForm 4Grant or award
- Feb 28, 2025SLQTChris Wolfe became an insiderForm 3New insider
- Aug 5, 2021DALSSEC Form 4 filed by Wolfe ChrisForm 4Sale back to the company
Compare Chris Wolfe with
- Chris Wolfe vs Earl H Devanny III1 shared
- Chris Wolfe vs Denise L Devine1 shared
- Chris Wolfe vs Donald L Hawks III1 shared
- Chris Wolfe vs Kavita Patel1 shared
- Chris Wolfe vs Raymond F Weldon1 shared
- Chris Wolfe vs Srdjan Vukovic1 shared
Other insiders at the same companies
- Earl H Devanny IIISLQT
- Denise L DevineSLQT
- Donald L Hawks IIISLQT
- Raymond F WeldonSLQT
- Kavita PatelSLQT
- Srdjan VukovicSLQT
- William Thomas Grant IIISLQT
- Robert Clay GrantSLQT
- Timothy Robert DankerSLQT
- Sarah Taylor AndersonSLQT
- Stephanie D. FisherSLQT
- Ryan Moore ClementSLQT
- Joshua Brandon MatthewsSLQT
- Daniel Allen BoulwareSLQT
- Ryan SouanSLQT
Questions about Chris Wolfe
- What is Chris Wolfe's role at DA32 Life Science Tech Acquisition Corp.?
- Chris Wolfe reports to the SEC as officer at DA32 Life Science Tech Acquisition Corp. (DALS), according to the latest filing on August 10, 2021. Chris Wolfe has also filed as director at SelectQuote, Inc. (SLQT).
- How many shares does Chris Wolfe own?
- After the latest filing that states it, Chris Wolfe directly owned 115,752 shares of SelectQuote, Inc. (SLQT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Chris Wolfe bought or sold stock recently?
- No open-market purchases or sales by Chris Wolfe are on file. The filings report grant or award, exercise or conversion of a derivative and sale back to the company.
- How do I get alerts when Chris Wolfe files?
- Follow Chris Wolfe on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Chris Wolfe filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Chris Wolfe (SEC CIK 0001472624). Totals count each trade once, skipping amendments whose original is on file, from Aug 10, 2021 on. View on SEC EDGAR · Get this as JSON